| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |